News
4317 posts · page 15 of 180
Waystar Weighs Sale as Software Sector Faces Market Pressure
Healthcare software firm Waystar considers sale amid market challenges, sources say.
AI in Healthcare: Trump's Push Amid Safety and Investment Worries
The Trump administration's AI healthcare initiative raises safety and investor influence concerns.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating to acquire Sofie Biosciences for $1 billion, enhancing its cancer diagnostics capabilities.
Home Care Trends Boost Demand for Eco-Friendly Pharma Packaging
The rise in home healthcare is reshaping pharmaceutical packaging, focusing on sustainability and smart solutions.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in First Quarter Post-IPO
Molbio Diagnostics, fresh from its IPO, reports Rs 52.7 crore profit in Q1, reversing last year's loss.
iOncology.ai: Indian AI Platform Showcased in BRICS Health Journal
iOncology.ai, an AI platform for cancer care, is spotlighted in the BRICS Health Journal, highlighting its potential in transforming oncology in emerging economies.
Waystar Weighs Sale Amid Falling Market Value, Sources Reveal
Healthcare software firm Waystar may consider a sale as its market value dips, insiders say.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
Federal initiatives aim to deploy A.I. in therapy and prescriptions, sparking safety debates.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion purchase of Sofie Biosciences, enhancing its diagnostic capabilities.
Manipal Hospitals Settles Rs 5,310 Crore Debt Using IPO Funds
Manipal Hospitals has cleared Rs 5,310 crore in debt via IPO funds, enhancing financial flexibility for expansion.
Molbio Diagnostics Achieves Rs 52.7 Cr Profit in Q1 After IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, reversing last year's loss post-IPO.
iOncology.ai: Indian AI Cancer Platform Spotlighted at BRICS Summit
iOncology.ai, an AI cancer care platform from India, gains international attention at the BRICS Summit, highlighting its potential in transforming cancer treatment.
Waystar Weighs Sale Amid Market Challenges, Sources Report
Healthcare software firm Waystar is exploring a potential sale, two years after going public.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
The U.S. government is advancing A.I. in healthcare, sparking safety and investor influence worries.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, enhancing its cancer diagnostic capabilities.
Molbio Diagnostics Achieves Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics reports Rs 52.7 crore profit in Q1, reversing last year's loss, driven by strong Truenat test-kit sales.
Indian AI Cancer Platform Gains Spotlight at BRICS Health Summit
iOncology.ai, an AI platform for cancer care, is featured in the BRICS Health Journal, highlighting its potential impact on cancer treatment in emerging economies.
Waystar Considers Sale Amid Stock Slump, Sources Reveal
Waystar is exploring strategic options, including a sale, following a 24% drop in its stock value this year.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
Federal initiatives aim to integrate A.I. in therapy and prescriptions, sparking safety and investor influence debates.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in cancer scan chemicals.
AIIMS Madurai to Launch Full OPD Services by January 2027, Court Informed
AIIMS Madurai will begin full outpatient services on January 1, 2027, as per the Centre's commitment to Madras HC.
Audit Reveals Key Improvements in Emergency Department Blood Gas Sampling
A clinical audit at a hospital has improved arterial blood gas sampling practices, enhancing patient care in emergency departments.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics posted a Rs 52.7 crore profit in Q1, reversing a Rs 23.94 crore loss from last year, thanks to Truenat test-kit demand.
Indian AI Cancer Care Platform Highlighted at BRICS Health Summit
iOncology.ai, developed by AIIMS and C-DAC, gains international attention at the BRICS Summit.